Building TLR7 Targeted Immune Agonists
Time: 11:30 am
day: Conference Day 2
Details:
- Examine the scientific rationale behind targeted immune agonists (TIA) targeting TLR7
- Assess the design of TIA conjugates and characterization of in vitro and in vivo functional activity
- Develop preclinical tools to de-risk TIAs potential for induction of immune-related adverse effects
